Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.5845
+0.0109 (1.90%)
At close: May 20, 2026, 4:00 PM EDT
0.5845
0.00 (0.00%)
After-hours: May 20, 2026, 6:30 PM EDT
Oragenics Market Cap
Oragenics has a market cap or net worth of $2.53 million as of May 20, 2026. Its market cap has decreased by -31.50% in one year.
Market Cap
2.53M
Enterprise Value
-3.62M
1-Year Change
-31.50%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $2.53M, an increase of 58.40%. That is a compound annual growth rate of 2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 2.60M | -21.21% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.25% |
| Dec 31, 2004 | 55.30M | 3,356.25% |
| Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.06M |
| GRI Bio | 2.93M |
| Azitra | 2.91M |
| Calidi Biotherapeutics | 2.85M |
| Valion Bio | 2.76M |
| SciSparc | 2.73M |
| Ensysce Biosciences | 2.60M |
| Decoy Therapeutics | 2.35M |